The Motley FoolWed, 24 Jun 2026 21:24:01 GMTOruka Therapeutics' Head of Finance Sold Over 10,000 Company Shares. What Does That Mean for Investors?ORKA+5.67%
Zacks Investment ResearchFri, 12 Jun 2026 17:01:14 GMTOruka Therapeutics, Inc. (ORKA) Upgraded to Buy: What Does It Mean for the Stock?ORKA+5.67%
Zacks Investment ResearchWed, 10 Jun 2026 14:56:04 GMTWall Street Analysts Believe Oruka Therapeutics, Inc. (ORKA) Could Rally 111.13%: Here's is How to TradeORKA+5.67%
Seeking AlphaMon, 27 Apr 2026 20:41:40 GMTOruka Therapeutics, Inc. (ORKA) Discusses Interim Results From EVERLAST-A Study of ORKA-001 in Moderate to Severe Plaque Psoriasis TranscriptORKA+5.67%
Seeking AlphaMon, 27 Apr 2026 19:51:39 GMTOruka Therapeutics: 'Strong Buy' On Half-Life Extended IL-23p19 Inhibitor ORKA-001ORKA+5.67%
BenzingaMon, 27 Apr 2026 14:47:53 GMTOruka Therapeutics Stock Explodes As Psoriasis Data Shows 'Highly Compelling' Skin ClearanceORKA+5.67%
The Motley FoolTue, 21 Apr 2026 16:22:39 GMTOruka Insider Sells $463K in Stock as Shares Skyrocket 650%, but Here's What Matters for InvestorsORKA+5.67%
